Japanese enceph vacc sa14-14-2, inactivated Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with japanese enceph vacc sa14-14-2, inactivated
L
- Lartruvo (olaratumab)
- leflunomide
- Lemtrada (alemtuzumab)
- lenalidomide
- leniolisib
- Lenmeldy (atidarsagene autotemcel)
- letrozole / ribociclib
- Leukeran (chlorambucil)
- Leustatin (cladribine)
- levamisole
- lifileucel
- Lipodox (doxorubicin liposomal)
- Lipodox 50 (doxorubicin liposomal)
- Liquid Pred (prednisone)
- lisocabtagene maraleucel
- Litfulo (ritlecitinib)
- LoCort (dexamethasone)
- lomustine
- loncastuximab tesirine
- Lonsurf (tipiracil / trifluridine)
- lovotibeglogene autotemcel
- Lupkynis (voclosporin)
- lurbinectedin
- Lutathera (lutetium lu 177 dotatate)
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- Lyfgenia (lovotibeglogene autotemcel)
- Lymphir (denileukin diftitox)
- lymphocyte immune globulin, anti-thy (equine)
- Lynparza (olaparib)
More about japanese enceph vacc sa14-14-2, inactivated
- japanese enceph vacc sa14-14-2, inactivated consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.